Companion Diagnostics expedited for SMEs
The Codex4SMEs Capitalisation initiative aims to widen the scope and impact of the initial Codex4SMEs project funded by the Interreg programme between 2017-2021.
The initial Codex4SMEs project was a support programme for small- and medium-sized enterprises (SMEs) developing companion diagnostics (Cdx). The project partners helped several SMEs in North-West Europe to optimise the time and cost-intensive product development process by offering a network and services such as support in biomarker validation or facilitated access to samples or know-how.
Under the follow-up Capitalisation Initiative, Codex4SMEs has enlarged its established network with three new partners from the Netherlands, Germany and Belgium. The original support scheme for SMEs will become a new Fast-Track Programme to accelerate the development process and time-to-market for novel diagnostic solutions. The knowledge and processes may be applied to other diagnostics solutions including COVID-19 diagnostics. Codex4SMEs expects the participating SMEs to gain market shares in Europe and on international markets, and increase their global competitiveness.Coordinator:
BioRegio STERN Management GmbH, DE
- BOM Holding BV, NL
- WestBIC, IE
- InnovationQuarter, NL
- MEDICEN PARIS REGION, FR
- Integrated BioBank of Luxembourg, LU
- EIT Health Germany GmbH, DE
- European Research Infrastructure for Translational Medicine, NL
- FlandersBio, BE
- accelopment Schweiz AG, CH